Tehran University of Medical Sciences

Science Communicator Platform

Share By
Prevalence of Vision Loss in High-Income Countries and in Eastern and Central Europe in 2020: Magnitude and Temporal Trends Publisher Pubmed



Bron AM ; Jonas JB ; Cicinelli MV ; Tapply I ; Fernandes AG ; Arrigo A ; Leveziel N ; Briant PS ; Vos T ; Resnikoff S ; Taylor HR ; Sedighi T ; Flaxman S ; Addo IY Show All Authors
Authors
  1. Bron AM
  2. Jonas JB
  3. Cicinelli MV
  4. Tapply I
  5. Fernandes AG
  6. Arrigo A
  7. Leveziel N
  8. Briant PS
  9. Vos T
  10. Resnikoff S
  11. Taylor HR
  12. Sedighi T
  13. Flaxman S
  14. Addo IY
  15. Adekiya TA
  16. Agodi A
  17. Agyemangduah W
  18. Ahinkorah BO
  19. Ahmad D
  20. Ahmed A
  21. Alahdab F
  22. Alfaar AS
  23. Almidani L
  24. Androudi S
  25. Anyasodor AE
  26. Azzam AY
  27. Barchitta M
  28. Bhaskar S
  29. Braithwaite T
  30. Butt ZA
  31. Santos FLCD
  32. Carneiro VLA
  33. Martins NC
  34. Dadras O
  35. Das S
  36. Dascalu AM
  37. Dervenis N
  38. Emamverdi M
  39. Fagbamigbe AF
  40. Fischer F
  41. Galluzzo L
  42. Gupta VB
  43. Gupta VK
  44. Hussain S
  45. Ilic IM
  46. Islam SMS
  47. Jacob L
  48. Jakovljevic M
  49. Jeong W
  50. Jozwiak JJ
  51. Kandel H
  52. Karaye IM
  53. Kayode GA
  54. Khodadoust E
  55. Kim J
  56. Kisa A
  57. Kisa S
  58. Koyanagi A
  59. Kurmi OP
  60. Leasher JL
  61. Lee M
  62. Lee SW
  63. Lee WC
  64. Liu X
  65. Loureiro JA
  66. Manafi N
  67. Maugeri A
  68. Mcalinden C
  69. Miller TR
  70. Moni MA
  71. Mulita A
  72. Murray CJL
  73. Natto ZS
  74. Nguyen DH
  75. Nguyen HQ
  76. Oancea B
  77. Odogwu NM
  78. Olagunju AT
  79. Ordak M
  80. Osuagwu UL
  81. Otstavnov N
  82. Papageorgiou E
  83. Pardhan S
  84. Parikh RR
  85. Patel J
  86. Pawar S
  87. Pesudovs K
  88. Petcu IR
  89. Podder V
  90. Qattea I
  91. Qureshi MF
  92. Rawaf S
  93. Sakshaug JW
  94. Samadzadeh S
  95. Sawhney M
  96. Seylani A
  97. Shorofi SA
  98. Singh JA
  99. Sousa RARC
  100. Tabatabaei SM
  101. Topouzis F
  102. Ubah CS
  103. Verras GI
  104. Wang Y
  105. Xiao H
  106. Yang L
  107. Yonemoto N
  108. You Y
  109. Zastrozhin MS
  110. Zielinska M
  111. Steinmetz JD
  112. Bourne R
  113. Bron A
  114. Fernandes A
  115. Taylor H
  116. Bikbov M
  117. Casson R
  118. Cheng CY
  119. Ehrlich JR
  120. Furtado JM
  121. Elizabeth Hartnett M
  122. Kahloun R
  123. Kempen J
  124. Khairallah M
  125. Khanna RC
  126. Van Lansingh C
  127. Naidoo KS
  128. Nangia V
  129. Nowak M
  130. Ramulu P
  131. Tahhan N
  132. Tsilimbaris M
  133. Bourne RRA

Source: Ophthalmic Epidemiology Published:2026


Abstract

Purpose: To estimate the prevalence of vision loss for 2020 in high-income countries (HICs) and Central/Eastern Europe and analyse evolving trends since 1990. Methods: Based on a systematic review of medical literature, prevalence of blindness, moderate and severe vision impairment (MSVI), mild vision impairment (VI), moderate VI and presbyopia were estimated for 1990, 2000, 2010, and 2020. Results: The study included 68 population-based studies. In the whole study region, the age-standardized prevalence (all ages) of blindness, MSVI, moderate VI, severe VI, mild VI, and presbyopia-related VI was 0.17% (95% CI:0.15–0.19), 2.27% (2.05–2.49), 2.06% (1.84–2.29), 0.21% (0.18–0.23), 1.79% (1.62–1.99), and 2.61% (1.88–3.48) respectively, with slightly higher rates for women than men. The prevalence rates were higher in Central/Eastern Europe than in the HIC, and lower than the global rates. Stratified between Australasia, high-income Asia Pacific region, high‐income North America, Western Europe, Central Europe, and Eastern Europe, the age-standardized prevalence of blindness changed between 2000 and 2020 for men aged 50+ years by −7.95% (−8.11/−7.78), −14.51% (−14.64/−14.38), +13.18% (+13.00/+13.36), −12.07% (−12.23/−11.91), −14.39% (−14.54/−14.23), and −23.59% (−23.72/−23.46), respectively, without significant sex-related differences. Highest increase was in high‐income North America (+13.18% (+13.00/+13.36)) and most marked reduction in Eastern Europe (−23.59% (−23.72/−23.46)). Estimated blind individuals were stratified as follows: Australasia, 68,866 (54,913–84,527), high-income Asia Pacific region, 535,124 (439,912–640,330), high‐income North America, 711,990 (575,977–867,402), Western Europe, 1,533,752 (1,218,371–1,898,343), Central Europe, 327,352 (264,513–398,083) and Eastern Europe, 789,618 (663,130–923,121). Conclusions: Age-standardized prevalence of blindness and MSVI have further decreased in HIC and Eastern/Central Europe (except for high‐income North America with an increase). © 2025 Taylor & Francis Group, LLC.